Cargando…
Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain
Effective, non-addictive therapeutics for chronic pain remain a critical need. While there are several potential therapeutics that stimulate anti-inflammatory mechanisms to restore homeostasis in the spinal dorsal horn microenvironment, the effectiveness of drugs for neuropathic pain are still inade...
Autores principales: | Westlund, Karin N., Zhang, Morgan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179195/ https://www.ncbi.nlm.nih.gov/pubmed/32138198 http://dx.doi.org/10.3390/molecules25051120 |
Ejemplares similares
-
Sustained relief of trigeminal neuropathic pain by a blood–brain barrier penetrable PPAR gamma agonist
por: Zhang, Morgan, et al.
Publicado: (2019) -
Urknall an der Elbe
por: Röthlein, B
Publicado: (2001) -
The Therapeutic Effectiveness of Full Spectrum Hemp Oil Using a Chronic Neuropathic Pain Model
por: Vigil, Jacob M., et al.
Publicado: (2020) -
Loss of PPARγ activity characterizes early protumorigenic stromal reprogramming and dictates the therapeutic window of opportunity
por: Caruso, Joseph A., et al.
Publicado: (2023) -
LINC01414/LINC00824 genetic polymorphisms in association with the susceptibility of chronic obstructive pulmonary disease
por: Zhou, Xiaoman, et al.
Publicado: (2021)